Inventor
PORTEUS MATTHEW H
US10 patents
Patents
10 patentsUS11306309B2Apr 19, 2022
Chemically modified guide RNAs for CRISPR/CAS-mediated gene regulation
UNIV LELAND STANFORD JUNIOR9 citations84
US11193141B2Dec 7, 2021
Nuclease-mediated genome editing of primary cells and enrichment thereof
UNIV LELAND STANFORD JUNIOR8 citations80
US11535846B2Dec 27, 2022
Chemically modified guide RNAS for CRISPR/Cas-mediated gene regulation
UNIV LELAND STANFORD JUNIOR4 citations71
US11634732B2Apr 25, 2023
Pharmaceutical compositions comprising gene-corrected primary cells
UNIV LELAND STANFORD JUNIOR1 citations69
US11492646B2Nov 8, 2022
Nuclease-mediated genome editing of primary cells
UNIV LELAND STANFORD JUNIOR3 citations69
US11851652B2Dec 26, 2023
Compositions comprising chemically modified guide RNAs for CRISPR/Cas-mediated editing of HBB
UNIV LELAND STANFORD JUNIOR0 citations61
US12442016B2Oct 14, 2025
Scarless genome editing through two-step homology directed repair
UNIV LELAND STANFORD JUNIOR0 citations60
US11692202B2Jul 4, 2023
Scarless genome editing through two-step homology directed repair
UNIV LELAND STANFORD JUNIOR1 citations60
US12584149B2Mar 24, 2026
Nuclease-mediated genome editing of primary cells and related kits
UNIV LELAND STANFORD JUNIOR0 citations58
US11903969B2Feb 20, 2024
Genome editing of graft-derived T-cells for post-transplant immunotherapy
UNIV LELAND STANFORD JUNIOR0 citations48